1ESTEY E. AML in older patients:are we making pro- gress[J] ? Best Pract Res Clin Haematol,2009,22 : 529-- 536.
2BOCHNER T, BERDEL W E, HAFERLACH C, et al. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative GroupEJ]. J Clin Oneol, 2009,27:61--69.
3APPELBAUM F R,GUNDACKER H, HEAD D R, et al. Age and acute myeloid leukemia[J]. BIood, 2006,107: 3481--3485.
4JULIUSSON G, ANTUNOVIC P, DEROLF A, et al. Age and acute myeloid leukemia: real world data on deci sion to treat and outcomes from the Swedish Acute Leu kemia Registry[J]. Blood,2009,113:4179--4187.
6ZIOGAS D C, VOULGARELIS M, ZINTZARAS E. A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the etd- erly[J]. Clin Ther, 2011,33 : 254-- 279.
7ALIBHAI S M,LEACH M,GUPTA V,et al. Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia [J]. Crit Rev Oneol Hemato, 2009,69:168--174.
8LOWENBERG B, OSSENKOPPELE G J, VAN PUTTEN W,et al. High-dose daunorubicin in older pa- tients with acute myeloid leukemia[J]. N Engl J Med, 2009,361 : 1235 -- 1248.
9BURNETT A K, MILLIGAN D, PRENTICE A G, et al. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoie acid for acute myeloid leukemia and high-risk myelodyspiastic syndrome in pa- tients not considered fit for intensive treatment[J].Cancer, 2007,10911110-- 1124.
3Deschler B,de Witte T,Mertelsmann R,et al.Treatment decisionmaking for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia:problems and approaches. Haematologica,2006,91:1513-1522.
4Kuendgen A,Germing U.Emerging treatment strategies for acute myeloid leukemia(AML) in the elderly.Cancer Treat Revi,2009,35:97-120.
5Vardiman JW,Harris NL,Brunning RD.The World Health Organization (WHO) classification of the myeloid neoplasms.Blood,2002,100:2292-2302.
6Charlson ME,Pompei P,Ales KL,et al.A new method of classifying prognostic comorbidity in longitudinal studies:development and validation.J Chron Dis,1987,40:373-383.
7D(o)hner H,Estey EH,Amadori S,et al.Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European Leukemia Net.Blood,2010,115:453-474.
8Kantarjian H,Ravandi F,O' Brien S,et al.Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.Blood,2010,116:4422-4429.
9Baz R,Rodriguez C,Fu AZ,et al.Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.Cancer,2007,110:1752-1759.
10Juliusson G,Antunovic P,Derolf A,et al.Age and acute myeloid leukemia:real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood,2009,113:4179-4187.
6Bumett AK,Russell NH,Kell J,et al.European development of clofara-bine as treatment for older patients with acute myeloid leukemia consid-ered unsuitable for intensive chemotherapy[J].J Clin Oncol, 2010; 28(14):2389-95.
7Krug U,Buchner T,Berdel WE,et al.The treatment of elderly patientswith acute myeloid leukemia[ J].Dtsch Arztebl Int ,2011; 108(51-52):863-70.
8张之南.白血病的诊断及疗效标准.3版.北京:科学出版社,2007:157.
9Bumett AK, Russell NH, Kell J, et al. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy. J Clin Oncol,2010,28(14) -2389-2395.
10Krug U, Buchner T, Berdel WE, et al. The treatment of elderly patients with acute myeloid leukemia. Dtsch Arztebl Int,2011, 108(51-52) :863-870.
